There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I was a bit worried last week’s ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Scotland’s rich culinary heritage ​is vital for the country’s economy – but it needs to be future-proofed, writes Dr Liz ...

As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...

In a recent webinar conducted by IQVIA and pharmaphorum, several experts gathered to give their views on the current state of UK biotech and what the future might look like. Steve Bates ...